Covaxin
Augmentation of Manufacturing Capacity for COVAXIN Production Under Mission COVID Suraksha
DCGI Approves Phase II/III Clinical Trial of COVAXIN Among Age Group of 2 to 18 Years
White House's Dr. Fauci Finds Bharat Biotech's Covaxin Capable to Fight 617 Variant of COVID